Broadspire® Adds Service to Help Decrease Workers Compensation Costs
Accurate, Soft-Tissue Diagnostic Test Offered through Partnership with Emerge Diagnostics
ATLANTA (April 1, 2016) - Broadspire has selected Emerge Diagnostics as its partner to provide Electrodiagnostic Functional Assessment (EFA) services to help control workers compensation costs. Broadspire is a leading global third-party administrator of workers compensation claims, liability claims and medical management services.
Broadspire recognizes the challenges payers face in managing workers compensation claims. The Broadspire-Emerge partnership aims to provide clients with reductions in the cost of claims involving soft-tissue injuries.
EFA is a computer-assisted, diagnostic test that evaluates musculoskeletal and soft-tissue pathology and functionality. Using an array of wireless sensors positioned on the skin surface, an EFA collects data while a patient is at rest and in motion. The resulting profile helps establish the location, nature, age and extent of an injury, or lack thereof. The EFA can be performed as a post-injury test only; or for selected job classes may be used to perform a baseline test. This choice allows Broadspire clients the opportunity to consider whether and how EFA could benefit them.
"One published study shows that the EFA test results positively affected the course of treatment, improved clinical and functional outcomes, increased patient satisfaction and decreased dispute litigation," said Dr. Jacob Lazarovic, MD, FAAFP, senior vice president and chief medical officer, Broadspire. "In fact, 98 of the 100 cases in this three-year study resulted in return to maximal medical improvement with no ratable impairment and full release to active duty."
Soft-tissue injuries are a leading cause of workers compensation claims and costs and a primary reason for time away from work. EFA provides objective, evidence-based measurements of the functional status of an injured worker; helps prevent inappropriate treatment, unnecessary surgery and false claims; and identifies return-to-work opportunities.
Broadspire, (www.choosebroadspire.com), a leading global third-party administrator, offers casualty claim, medical management, accident and health, and disability and leave management solutions, helping increase employee productivity and reducing the cost of risk through early intervention, professional expertise and data analytics. As a Crawford Company, Broadspire is based in Atlanta, Ga. Services are offered by Crawford & Company® under the Broadspire brand in countries outside the U.S.
Based in Atlanta, Ga., Crawford & Company (www.crawfordandcompany.com) is one of the world`s largest independent providers of claims management solutions to the risk management and insurance industry as well as self-insured entities, with an expansive global network serving clients in more than 70 countries. The Crawford Solution(TM) offers comprehensive, integrated claims services, business process outsourcing and consulting services for major product lines including property and casualty claims management, workers compensation claims and medical management, and legal settlement administration. The Company`s shares are traded on the NYSE under the symbols CRD-A and CRD-B.
About Emerge Diagnostics
Headquartered in Carlsbad, CA, Emerge Diagnostics (www.emergedx.com) delivers a new way to determine the location and age of soft tissue injuries. The company`s technology provides the most comprehensive and actionable pre- and post-injury test to determine whether an injury actually arose in the workplace. Emerge Diagnostics works with employers, occupational health clinics and insurance carriers/TPAs to create better patient outcomes and reduced costs. Emerge is leading the way with technological development and ongoing innovation to improve workplace injury outcomes and return-to-work times.
# # #
For more information, please contact:
Kara Grady, vice president for corporate communications
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Crawford & Company via GlobeNewswire